Cochlear enlightenment
Current Opinion in Neurobiology · 2026-08 · 99 · 103222
DOI: 10.1016/j.conb.2026.103222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Neurobiology, 2026-08. Verfasst von Philip X Joris. Beteiligte Einrichtung: Laboratory of Auditory Neurophysiology, University of Leuven, Herestraat 49 O/N2 bus 1021, B-3000 Leuven, Belgium. Electronic address: Philip.Joris@k…. Hauptthemen laut MEDLINE: Cochlea. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Of all mammalian receptor organs, the cochlea is the least understood. How it performs its most fundamental feat-the filtering of sound into different frequency bands over an enormous range of intensities-is still shrouded in mystery. Two of its neural systems, one a component of its dual output to the central nervous system (CNS) and the other a component of its dual feedback from the CNS, are in key cochlear positions but have escaped physiological study. At the same time, cochlear impairments affect an enormous and growing fraction of the population. Here we briefly highlight, from a system rather than molecular or biophysical viewpoint, recent breakthroughs that have forced a re-examination of assumptions deemed quite safe not too long ago and that herald a new renaissance in the study of this intricate sensory organ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Auditory Neurophysiology, University of Leuven, Herestraat 49 O/N2 bus 1021, B-3000 Leuven, Belgium. Electronic address: Philip.Joris@kuleuven.be.
Zitieren
APA
Joris, P. X. (2026). Cochlear enlightenment. Current Opinion in Neurobiology, 99, 103222. https://doi.org/10.1016/j.conb.2026.103222
Vancouver
Joris PX. Cochlear enlightenment. Current Opinion in Neurobiology. 2026;99:103222. doi:10.1016/j.conb.2026.103222
BibTeX
@article{Joris2026,
author = {Joris, Philip X},
title = {Cochlear enlightenment},
journal = {Current Opinion in Neurobiology},
year = {2026},
volume = {99},
pages = {103222},
doi = {10.1016/j.conb.2026.103222}
}
EUVIMED